Anlotinib for Patients With Metastatic Renal Cell Carcinoma...

Frontiers in Oncology 2020 / 5 Vol. 10

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial

Ma, Jianhui, Song, Yan, Shou, Jianzhong, Bai, Yuxian, Li, Hanzhong, Xie, Xiaodong, Luo, Hong, Ren, Xiubao, Liu, Jiyan, Ye, Dingwei, Bai, Xianzhong, Fu, Cheng, Qin, Shukui, Wang, Jinwan, Zhou, Ai-Ping
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2020.00664
Date:
May, 2020
File:
PDF, 809 KB
2020
Conversion to is in progress
Conversion to is failed